Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$536.87 USD
+5.01 (0.94%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $536.96 +0.09 (0.02%) 7:32 PM ET
2-Buy of 5 2
C Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$536.87 USD
+5.01 (0.94%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $536.96 +0.09 (0.02%) 7:32 PM ET
2-Buy of 5 2
C Value C Growth A Momentum B VGM
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher Scientific (TMO) Stock Moves 0.35%: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $576.38 in the latest trading session, marking a +0.35% move from the prior day.
Thermo Fisher (TMO) Expands to Boost Commercial Manufacturing
by Zacks Equity Research
Thermo Fisher's expansion in Bourgoin is built on the company's investments in small molecule solutions.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $579.86 in the latest trading session, marking a +0.64% move from the prior day.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $562.97, marking a +1.41% move from the previous day.
Thermo Fisher (TMO) Partners With ArsenalBio for Cancer R&D
by Zacks Equity Research
Thermo Fisher's (TMO) latest collaboration with ArsenalBio supports the latter's clinical manufacturing of autologous T-cell therapies for advanced cancer treatment.
Thermo Fisher (TMO) Opens New Cell Therapy Facility at UCSF
by Zacks Equity Research
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.
The Zacks Analyst Blog Highlights Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys
by Zacks Equity Research
Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog.
Top Stock Reports for Berkshire Hathaway, Roche & Thermo Fisher Scientific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Roche Holding AG (RHHBY) and Thermo Fisher Scientific Inc. (TMO).
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $558.26 in the latest trading session, marking a +0.55% move from the prior day.
TMO vs. SONVY: Which Stock Is the Better Value Option?
by Zacks Equity Research
TMO vs. SONVY: Which Stock Is the Better Value Option?
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $555.19 in the latest trading session, marking a +0.16% move from the prior day.
Strength Seen in Inogen (INGN): Can Its 5.0% Jump Turn into More Strength?
by Zacks Equity Research
Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $547.34, marking a -1.75% move from the previous day.
Thermo Fisher (TMO) Introduces iCAP RQplus ICP-MS Analyzer
by Zacks Equity Research
Thermo Fisher's (TMO) new analyzer streamlines everyday analyses in environmental, food, pharmaceutical and industrial testing laboratories.
Thermo Fisher (TMO) Unveils New Line of Low-Flow HPLC Columns
by Zacks Equity Research
Thermo Fisher's (TMO) newest addition of a new line of low-flow HPLC columns that improve separation performance and stability of biologically complex samples.
TMO or IDXX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TMO vs. IDXX: Which Stock Is the Better Value Option?
BD (BDX) Boosts Molecular Diagnostics Portfolio With New Tests
by Zacks Equity Research
Recent developments in the Molecular Diagnostics space have been aiding key MedTech players like BD (BDX) to boost their business.
Is IPSEN (IPSEY) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how IPSEN (IPSEY) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $559.44, marking a +1.95% move from the previous day.
Why Is Thermo Fisher (TMO) Down 6.5% Since Last Earnings Report?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) Exits Business Line to Focus More on Core Units
by Zacks Equity Research
Humana (HUM) will depart from the Employer Group Commercial Medical Products business so that it can invest more funds to grow its core Insurance business lines.
Zacks.com featured highlights include Everest Re Group, Thermo Fisher Scientific and Sony Group
by Zacks Equity Research
Everest Re Group, Thermo Fisher Scientific and Sony Group are part of the Zacks Screen of the Week article.
3 Stocks With Sales Growth to Buy Amid Persistent Inflation
by Swayta Shah
Sales growth is vital for the survival of a business, even during an economic slowdown. Everest Re (RE), Thermo Fisher (TMO) and Sony Group (SONY) are recording top-line growth.
TMO vs. IDXX: Which Stock Is the Better Value Option?
by Zacks Equity Research
TMO vs. IDXX: Which Stock Is the Better Value Option?